Quinuclidinol derivatives as muscarinic receptor antagonists

Details for Australian Patent Application No. 2007336054 (hide)

Owner AstraZeneca AB

Inventors Millichip, Ian; Teobald, Barry; Ford, Rhonan; Mete, Antonio

Agent Freehills

Pub. Number AU-A-2007336054

PCT Pub. Number WO2008/075005

Priority 60/870,638 19.12.06 US

Filing date 17 December 2007

Wipo publication date 26 June 2008

International Classifications

A61P 11/12 (2006.01) Drugs for disorders of the respiratory system

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

C07D 295/037 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/075005 Priority application(s): WO2008/075005

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007336057-A barrier

2007336051-Phase based measurement corrections